Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today? [electronic resource]
- The oncologist Jan 2009
- 29-39 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1549-490X
10.1634/theoncologist.2008-0167 doi
Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Antineoplastic Agents--therapeutic use Cetuximab Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Colorectal Neoplasms--drug therapy ErbB Receptors--antagonists & inhibitors Female Humans Male Neoplasm Metastasis Panitumumab Randomized Controlled Trials as Topic